VC  Nazem and Company

     Office Locations:

570 Lexington Ave., 15th Floor
New York, NY 10022
Phone: 212-371-7900
Fax: 212-371-2150



  • Early
  • Expansion
  • Growth
  • Seed



  • Information Technology
  • Life Sciences & Healthcare



    Nazem and Company, established in 1976, is an alternative asset management investment firm. As both venture investors and money managers, Nazem and Company's aim is to create enduring assets and generate superior returns for its partners, while producing a stream of innovative products and services for new growth industries. The firm invests in all stages of enterprise development, from seed stage to follow-on financings to late-stage pre-IPO financings. It also invests in stress and turnaround situations where the firm can lead the reorganization efforts. The firm focuses primarily on companies in the healthcare and technology sectors. Transatlantic Venture Partners is a venture capital fund organized in the Netherlands Antilles in 1995 and is co-managed by Nazem and Company and BNP Paribas (formerly Banque Nationale de Paris). Over the last 35 years, Nazem and Company has shepherded some 300 companies, taken more than 50 public, and some two dozen of them have achieved revenues and market values in excess of $1 billion.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Desiree Wong Executive Assistant
    Fred Nazem Founder and Managing Partner


    Portfolio companies include:

      Applied ImmuneScience
        web link

      APS Healthcare
        web link

      Avicenna Systems
        web link

        web link

      Repeater Technologies
        web link


    Recent News:

      There is no recent news for Nazem and Company.